About

This Blog is intended to build an online dialogue about Castleman’s disease. Get information here about clinical trials, treatment issues and more.

Bart Barlogie

Bart Barlogie

About Bart Barlogie
Bart Barlogie, MD, was educated in Germany and earned his MD from Heidelberg University.  Following residency training at the Universities of Munich and Muenster, he joined the University of Texas MD Anderson Hospital and Tumor Research Institute in 1974 where he worked under Emil J Freireich and colleagues in Developmental Therapeutics.  Eventually, he served as Chairman of the Department of Hematology.  In 1989, he accepted the position of Director of Hematology/Oncology and Director of Research at the Arkansas Cancer Research Center, University of Arkansas for Medical Sciences.  In recognition of his institutional leadership role in myeloma, he was named the first Director of a newly established Myeloma and Transplantation Research Center and, later that year, he also became the Director of the Arkansas Cancer Research Center.  In 2001, Dr. Barlogie stepped down as the Director of the Arkansas Cancer Research Center to develop its Myeloma and Transplantation Research Center into the world’s first Myeloma Institute for Research and Therapy .

  1. No comments yet.
(will not be published)

  1. No trackbacks yet.